RSS-Feed abonnieren
DOI: 10.1055/s-2003-43365
Synthesis of 7,8-Dihydroxy-5-hydroxymethyl-2-phenyl-chroman-4-one; the Aglycon of Actinoflavoside
Publikationsverlauf
Publikationsdatum:
26. November 2003 (online)
![](https://www.thieme-connect.de/media/synlett/200401/lookinside/thumbnails/10.1055-s-2003-43365-1.jpg)
Abstract
The first synthesis of 7,8-dihydroxy-5-hydroxymethyl-2-phenyl-chroman-4-one, the aglycon part of a new-type glucoside, actinoflavoside, was accomplished. The regioselective oxidation of the methyl group at the 5-position in 7,8-dihydroxy-5-methyl-2-phenyl-chroman-4-one derived from 3,4,5-trimethoxytoluene was performed by use of ammonium cerium(VI) nitrate (CAN).
Key words
flavanon - natural product - oxidation - CAN - DDQ
- 1
Pigman W.Horton D. The Carbohydrate Vol. IIA: Academic Press; New York: 1970. - 2
Jiang ZD.Jensen PR.Fenical W. Tetrahedron Lett. 1997, 38: 5065 - 4
Reichel L.Proksch G. Liebigs Ann. Chem. 1971, 745: 59 - 5
McOmie JFW.West DE. Org. Synth., Coll. Vol. V Wiley and Sons; New York: 1973. p.412 - 6
Jackman LM. Advances in Organic Chemistry, Methods and Results Vol. II:Raphael RA.Taylor EC.Wynberg H. Interscience; New York: 1960. p.329 - 7
Walker D.Hiebert JD. Chem. Rev. 1967, 67: 153 - 8
Becker H.-D. Chemistry of the Quinonoid CompoundsPatai S. Wiley; New York: 1974. p.335 - 9
Turner AB. Synthetic ReagentsPizey JS. Wiley; New York: 1977. p.193 - 10
Ho TL. Synthesis 1973, 347 - 11
Matsuura S.Iinuma M.Ishikawa K.Kagei K. Chem. Pharm. Bull. 1978, 26: 305
References
Compound 2 was reported as a recemic form. [2] Actinoflavoside 1 was also isolated as a 1:1 diastereomeric mixture. It is not to be denied completely that isomerization of 1 occurred in the process of isolation.
12To an HOAc solution (100 mL) of 7,8-di-benzyloxy-5-methyl-2-phenyl-chloman-4-one (11) (500 mg, 1.11 mmol) was added CAN (2.4 g, 4.44 mmol). The mixture was stirred for 12 h at r.t., then neutralized with 1 M NaOH. A solution was diluted with CH2Cl2 and washed with H2O. The organic layer was dried over MgSO4 and concentrated in vacuo. The residue was purified by silica gel column chromatography (benzene:acetone = 99:1) to afford 7,8-di-benzyloxy-5-acetoxymethyl-2-phenyl-chloman-4-one (18) (303 mg, 54%) and 7,8-di-benzyloxy-5-nitroxymethyl-2-phenyl-chloman-4-one (19) (79 mg, 14%), respectively. Compound 18. 1H NMR (400 MHz, CDCl3, 25 °C): δ = 7.20-7.48 (m, 15 H, Ph), 6.74 (s, 1 H, H-6), 5.52 (q, 2 H, J = 15.4 Hz, H-11), 5.39 (dd, 1 H, J = 2.9, 12.8 Hz, H-2), 5.22, 5.05 (each s, 4 H, benzyl), 3.01 (dd, 1 H, J = 16.7, 12.8 Hz, H-3a), 2.86 (dd, 1 H, J = 16.7, 2.9 Hz, H-3b), 2.11 (s, 3 H, Ac). 13C NMR (100 MHz, CDCl3, 25 °C): δ = 191.8, 170.4, 157.1 (C-9), 156.9 (C-8), 138.7, 137.2, 136.2, 135.6 (C-7), 135.4 (C-10), 128.7, 128.5, 128.2, 128.1, 128.0, 127.2, 125.9, 113.3 (C-5), 106.1 (C-6), 79.2 (C-2), 75.3, 70.9, 64.8 (C-11), 45.5 (C-3), 21.0. Compound 19. 1H NMR (400 MHz, CDCl3, 25 °C):
δ = 7.20-7.44 (m, 15 H, Ph), 6.72 (s, 1 H, H-6), 5.88 (q, 2 H, J = 15.0 Hz, H-11), 5.39 (dd, 1 H, J = 3.2, 13.2 Hz, H-2), 5.20, 5.05 (each s, 4 H, benzyl), 3.03 (dd, 1 H, J = 16.9, 13.2 Hz, H-3a), 2.88 (dd, 1 H, J = 16.9, 3.2 Hz, H-3b). 13C NMR (100 MHz, CDCl3, 25 °C): δ = 192.0, 157.2 (C-9), 157.1 (C-8), 138.4, 137.0, 136.5 (C-7), 135.7, 131.5 (C-10), 128.8, 128.7, 128.6, 128.5, 128.3, 128.2, 128.1, 127.4, 126.0, 113.4 (C-5), 106.7 (C-6), 79.3 (C-2), 75.3, 72.7 (C-11), 71.0, 45.3 (C-3).
Selected spectral data for synthetic aglycon 2: 1H NMR (400 MHz, CD3OD, 25 °C): δ = 7.23-7.45 (m, 5 H, Ph), 6.67 (s, 1 H, H-6), 5.50 (dd, 1 H, J = 3.1, 12.1 Hz, H-2), 4.69 (q, 2 H, J = 15.2 Hz, H-11), 3.08 (dd, 1 H, J = 16.7, 12.1 Hz, H-3a), 2.82 (dd, 1 H, J = 16.7, 3.1 Hz, H-3b). 13C NMR (100 MHz, CD3OD, 25 °C): δ = 194.8 (C-4), 153.5 (C-9), 153.2 (C-8), 140.4, 137.8 (C-10), 133.1 (C-7), 129.7, 129.7, 127.5, 112.9 (C-5), 110.0 (C-6), 80.8 (C-2), 64.4 (C-11), 46.1 (C-3).